These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 2441516)
1. Basement membrane proteins and reticulin in a normal thymus and the thymus in myasthenia gravis. Karttunen T Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):245-52. PubMed ID: 2441516 [TBL] [Abstract][Full Text] [Related]
2. Nonneoplastic and nonhyperplastic thymus in myasthenia gravis. An immunohistochemical study with double immunoenzymatic labeling of basement membrane and cellular components. Eimoto T; Kusano T; Ando K; Kikuchi M; Shirakusa T; Kawanami S Am J Clin Pathol; 1990 Jul; 94(1):36-43. PubMed ID: 2193507 [TBL] [Abstract][Full Text] [Related]
3. Thymic extracellular matrix in myasthenia gravis. II. Immunohistochemical evidence for increased type I collagen degradation. Savino W; Emonard H; Grimaud JA J Neuroimmunol; 1988 Jun; 18(3):223-30. PubMed ID: 3366881 [TBL] [Abstract][Full Text] [Related]
4. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Meinl E; Klinkert WE; Wekerle H Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638 [TBL] [Abstract][Full Text] [Related]
5. Characterization of extracellular matrix in non-Hodgkin's lymphomas. Karttunen T; Apaja-Sarkkinen M; Alavaikko M; Blanco G; Aine R; Järvinen M; Autio-Harmainen H Pathol Res Pract; 1988 Nov; 183(6):735-46. PubMed ID: 3265512 [TBL] [Abstract][Full Text] [Related]
6. Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis. Kirchner T; Schalke B; Melms A; von Kügelgen T; Müller-Hermelink HK Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):237-57. PubMed ID: 2879380 [TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. Sempowski GD; Hale LP; Sundy JS; Massey JM; Koup RA; Douek DC; Patel DD; Haynes BF J Immunol; 2000 Feb; 164(4):2180-7. PubMed ID: 10657672 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic changes of the subseptal thymic epithelium in myasthenia gravis. Savino W; Takacs L; Monostori E; Dardenne M Thymus; 1988-1989; 12(2):111-6. PubMed ID: 2471300 [TBL] [Abstract][Full Text] [Related]
9. Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis. Villegas JA; Bayer AC; Ider K; Bismuth J; Truffault F; Roussin R; Santelmo N; Le Panse R; Berrih-Aknin S; Dragin N J Autoimmun; 2019 Mar; 98():59-73. PubMed ID: 30578016 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and enzyme histochemical contributions to the problem concerning the role of the thymus in the pathogenesis of myasthenia gravis. Palestro G; Tridente G; Botto Micca F; Novero D; Valente G; Godio L Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(2):173-86. PubMed ID: 6139909 [TBL] [Abstract][Full Text] [Related]
11. Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells. Matsumoto Y; Furuya A; Kobayashi T; Tsukagoshi H J Neurol Sci; 1986 Sep; 75(2):121-33. PubMed ID: 3760907 [TBL] [Abstract][Full Text] [Related]
12. Extracellular matrix of the human thymus: immunofluorescence studies on frozen sections and cultured epithelial cells. Berrih S; Savino W; Cohen S J Histochem Cytochem; 1985 Jul; 33(7):655-64. PubMed ID: 3891843 [TBL] [Abstract][Full Text] [Related]
13. Microenvironments in the normal thymus and the thymus in myasthenia gravis. Bofill M; Janossy G; Willcox N; Chilosi M; Trejdosiewicz LK; Newsom-Davis J Am J Pathol; 1985 Jun; 119(3):462-73. PubMed ID: 3874554 [TBL] [Abstract][Full Text] [Related]
14. Thymic extracellular matrix in human malnutrition. Lyra JS; Madi K; Maeda CT; Savino W J Pathol; 1993 Nov; 171(3):231-6. PubMed ID: 8277371 [TBL] [Abstract][Full Text] [Related]
15. Thymic hyperplasia and neoplasia: a review of current concepts. Levine GD; Rosai J Hum Pathol; 1978 Sep; 9(5):495-515. PubMed ID: 361541 [TBL] [Abstract][Full Text] [Related]
16. Basement membrane proteins in the spleen: immunohistochemical demonstration and relation to reticulin. Apaja-Sarkkinen M; Alavaikko M; Karttunen T; Autio-Harmainen H Histopathology; 1986 Mar; 10(3):295-302. PubMed ID: 3516841 [TBL] [Abstract][Full Text] [Related]
17. B-cell compartment in the thymus of patients with myasthenia gravis and control subjects. Christensson B; Biberfeld P; Matell G Ann N Y Acad Sci; 1988; 540():293-7. PubMed ID: 3264672 [TBL] [Abstract][Full Text] [Related]
18. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis. Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741 [TBL] [Abstract][Full Text] [Related]
19. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour. Chang KC; Wu MH; Jones D; Chen FF; Tseng YL J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804 [TBL] [Abstract][Full Text] [Related]
20. [Distribution of CD44 highly-positive cells in relation to hyaluronic acid and basement membrane in myasthenia gravis thymus]. Nagane Y; Utsugisawa K Rinsho Shinkeigaku; 1997 Sep; 37(9):790-5. PubMed ID: 9430992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]